Adaptive Biotechnologies Corp share price logo

Adaptive Biotechnologies Corp Share Price

NASDAQ: ADPT

Small Cap

$13.08

+0.47

(+3.73%)

as on

Adaptive Biotechnologies Corp Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $12.52
    $13.14
    downward going graph

    4.28%

    Downside

    0.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.98
    $13.68
    downward going graph

    69.56%

    Downside

    4.59%

    Upside

    downward going graph

Adaptive Biotechnologies Corp share price movements today

Previous Close
$12.61
Open
$12.62
Volume
1.2M
Day's Low - High
$12.52 - $13.14
52 Week Low - High
$3.98 - $13.68

Adaptive Biotechnologies Corp Historical Returns

1 Month Return
-3.3 %
3 Month Return
+ 22.19 %
1 Year Return
+ 173.54 %
3 Year Return
+ 49.41 %
5 Year Return
-72.56 %

Adaptive Biotechnologies Corp Stock Fundamentals & Key Indicators

Check Adaptive Biotechnologies Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-0.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.23

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-102.8M

Revenue (TTM)

205.2M

Profit Margin

-59.07%

Return On Equity TTM

25303500.00%

Adaptive Biotechnologies Corp Stock Valuation

Track how Adaptive Biotechnologies Corp P/E has moved over time to understand its valuation trends.

Adaptive Biotechnologies Corp in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-3.23x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.23x

Adaptive Biotechnologies Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adaptive Biotechnologies Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Adaptive Biotechnologies Corp image
Adaptive Biotechnologies Corp
BUY$1.9B-72.56%-3.23-59.07%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B256.98%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.1B47.85%28.0731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Adaptive Biotechnologies Corp Stock including INR - Dollar returns

The Adaptive Biotechnologies Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Adaptive Biotechnologies Corp investment value today

Current value as on today

₹2,88,716

Returns

₹1,88,716

(+188.72%)

Returns from Adaptive Biotechnologies Corp Stock

₹1,83,731 (+183.73%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Adaptive Biotechnologies Corp Stock

Based on 14 analysts

BUY

78.57%

Buy

21.43%

Hold

0.00%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Adaptive Biotechnologies Corp. Average target price of $14

Adaptive Biotechnologies Corp Share Price Target

Get share price movements and forecasts by analysts on Adaptive Biotechnologies Corp.

What analysts predicted

6.57%UPSIDE

Target Price

$14

Current Price

$13.08

Analyzed by

14 Analysts

Target

$14.00

Adaptive Biotechnologies Corp target price $14, a slight upside of 6.57% compared to current price of $13.08. According to 14 analysts rating.

Adaptive Biotechnologies Corp Stock's Interest Amongst Investors

Search interest for Adaptive Biotechnologies Corp Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Adaptive Biotechnologies Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
37
48
37
45
41
43
46
47
52
58
Gross Profit
18
31
18
20
23
21
29
29
35
40
Operating Income
-57
-47
-50
-45
-48
-39
-32
-33
-29
-25
EBITDA
-48
-36
-39
-61
-39
-38
-24
-26
-29
-18
Interest Expense
3
3
3
3
2
2
2
2
2
2
Depreciation
5
5
5
5
5
5
4
4
4
4
Income Before Tax
-57
-47
-50
-69
-47
-46
-32
-33
-29
-25
Income Tax Expense
4
3
-5
0
4
0
-
-
-
-
Net Income
-57
-47
-50
-69
-47
-46
-32
-33
-29
-25
Net Profit Margin
-153.26%
-97.72%
-132.65%
-151.67%
-113.45%
-107.02%
-69.07%
-70.99%
-56.92%
-43.50%

Adaptive Biotechnologies Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
38
55
85
98
154
185
170
178
Gross Profit
22
35
62
75
105
127
94
106
Operating Income
-44
-49
-78
-152
-208
-200
-227
-162
EBITDA
-37
-43
-70
-144
-193
-167
-189
-128
Interest Expense
-
-
-
-
1
4
13
11
Depreciation
5
6
7
8
13
20
22
19
Income Before Tax
-42
-46
-68
-146
-207
-200
-225
-159
Income Tax Expense
0
3
-9
-6
-1
-57
0
-
Net Income
-42
-46
-58
-139
-205
-142
-225
-159
Net Profit Margin
-111.40%
-83.44%
-69.14%
-141.93%
-133.22%
-76.88%
-132.29%
-89.12%

Adaptive Biotechnologies Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-47
-50
-69
-47
-46
-32
-33
-29
-25
Operating Cash Flow
-23
-46
-26
-38
-17
-27
-12
-28
-12
Investing Cash Flow
37
26
3
44
5
5
22
25
3
Financing Cash Flow
1
0
0
0
0
0
0
5
1
Change in Cash
15
-20
-23
6
-11
-18
9
2
-7

Adaptive Biotechnologies Corp Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-46
-68
-146
-207
-200
-225
-159
Operating Cash Flow
-32
205
-149
-192
-183
-156
-95
Investing Cash Flow
0
-481
-117
181
2
129
77
Financing Cash Flow
1
319
293
27
132
2
0
Change in Cash
-30
43
26
15
-48
-24
-17

Global Institutional Holdings in Adaptive Biotechnologies Corp

Funds
Holdings
Viking Global Investors LP
19.7%
Rubric Capital Management LP
8.61%
BlackRock Inc
8.03%
Vanguard Group Inc
7.32%
Ameriprise Financial Inc
4.36%
See all

Insights on Adaptive Biotechnologies Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -33.69M → -25.61M (in $), with an average increase of 14.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ADPT stock has moved up by 73.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ADPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 41.87M → 58.87M (in $), with an average increase of 6.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 74.1%

About Adaptive Biotechnologies Corp

we are a commercial-stage, biotechnology organization located in the hot biotech locations of seattle, washington and south san francisco, ca. our world class scientists have invented a patent-pending technology that combines advances in high-throughput sequencing with state-of-the-art computer infrastructure to provide an in-depth analysis of the t- and b-cell repertoire, a specific and important part of the immune system. this information is driving the r&d community to support the fights against cancer, auto-immune disease, and much, much more. we're often asked to describe our company culture. it is very easy ... we're a hard working group of top-notch individuals who are passionate about wanting to make a difference in the world. we know our employees are our most valuable asset, and every employee’s contribution is appreciated. open communication and collaboration are always encouraged in every interaction throughout the organization. we have high expectations of ourselves, and
OrganisationAdaptive Biotechnologies Corp
Headquarters1165 Eastlake Avenue East, Seattle, WA, United States, 98109
IndustryCommercial Services
CEOMr. Chad M. Robins M.B.A.
E-voting on sharesClick here to vote

Key Management of Adaptive Biotechnologies Corp

Name

Title

Ms. Julie Rubinstein

President & COO

Ms. Clarice McCauley

Interim General Counsel, Corporate Secretary, VP & Chief Compliance Officer

Ms. Susan Bobulsky

Chief Commercial Officer of MRD

Mr. Chad M. Robins M.B.A.

Co-Founder, CEO & Chairman

Mr. Kyle Piskel

VP, CFO & Principal Accounting Officer

Dr. Sharon Benzeno Ph.D.

Chief Commercial Officer of Immune Medicine

Mr. Christopher Carlson Ph.D.

Founder

Ms. Karina Calzadilla

Vice President of Investor Relations

Mr. Francis T. Lo

Chief People Officer

Dr. Harlan S. Robins Ph.D.

Co-Founder & Chief Scientific Officer

FAQs

What is Adaptive Biotechnologies Corp share price today?

Adaptive Biotechnologies Corp share price today is $13.08 as on at the close of the market. Adaptive Biotechnologies Corp share today touched a day high of $13.14 and a low of $12.52.

What is the 52 week high and 52 week low for Adaptive Biotechnologies Corp share?

Adaptive Biotechnologies Corp share touched a 52 week high of $13.68 on and a 52 week low of $3.98 on . Adaptive Biotechnologies Corp stock price today i.e. is closed at $13.08,which is 4.39% down from its 52 week high and 228.56% up from its 52 week low.

What is Adaptive Biotechnologies Corp's market capitalisation today?

Adaptive Biotechnologies Corp market capitalisation is $0.00T as on .

How to invest in Adaptive Biotechnologies Corp Stock (ADPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adaptive Biotechnologies Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptive Biotechnologies Corp Shares that will get you 0.1147 shares as per Adaptive Biotechnologies Corp share price of $13.08 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adaptive Biotechnologies Corp Stock (ADPT) from India?

Indian investors can start investing in Adaptive Biotechnologies Corp (ADPT) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Adaptive Biotechnologies Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Adaptive Biotechnologies Corp share’s latest price of $13.08 as on September 16, 2025 at 1:29 am IST, you will get 0.7645 shares of Adaptive Biotechnologies Corp. Learn more about fractional shares .

What are the returns that Adaptive Biotechnologies Corp has given to Indian investors in the last 5 years?

Adaptive Biotechnologies Corp stock has given -72.56% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?